IP Library › Granted Patent US 10,308,976
Granted Patent B2
US 10,308,976 · App. 13/514,734 · Granted Jun 4, 2019

Selective lysis of cells

Inventors: Bart Edward Jozef Gusta Van Meerbergen (AE Eindhoven, NL); Oana Mihaela Piciu (AE Eindhoven, NL); Ron Gill (AE Eindhoven, NL); Kristiane Anne Schmidt (AE Eindhoven, NL); Sieglinde Neerken (AE Eindhoven, NL); Marc Wilhelmus Gijsbert Ponjee (AE Eindhoven, NL); Zeynep Seflek (AE Eindhoven, FR); Roel Penterman (AE Eindhoven, NL); Paul Arnold Van De Wiel (AE Eindhoven, NL)
Assignee: Koninklijke Philips N.V.
C12Q1/6806C12N1/06C12Q1/689C12Q1/6895G01N33/48
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,308,976
App. No.
13/514,734
Granted
Jun 4, 2019
Kind
B2
Abstract

Methods and devices for the selective lysis of cells in a sample comprising micro-organisms such as bacteria are provided. The selective lysis is obtained by incubating the sample in a non-ionic detergent under alkaline conditions.

Claims (19)

1. A method for detecting the presence of micro-organisms contained or suspected to be contained within a mammalian blood sample, the method comprising the steps of:

providing the mammalian blood sample containing or suspected to contain the micro-organisms, wherein:

said mammalian blood sample comprises whole blood that has not been cultivated, said whole blood including blood plasma and eukaryotic blood cells,

said mammalian blood sample has a volume between 1 ml and 20 ml,

said micro-organisms are selected from the group consisting of bacteria and fungi, and

there are less than 10,000 micro-organisms per milliliter of the mammalian blood sample,

adding a selective lysis buffer at a selected concentration to the mammalian blood sample to obtain a final solution having a pH level of around 9.5 or higher, said selective lysis buffer including (i) a non-ionic detergent and (ii) an alkaline buffer, said non-ionic detergent present in a concentration of between 0.1% and 5% (w/v % or v/v %),

wherein the selected concentration of the selective lysis buffer in the final solution is a concentration that achieves said pH level of around 9.5 or higher for the final solution, with a volume of the selective lysis buffer that is between 200% and 10% of a volume of the mammalian blood sample;

incubating the final solution in the presence of the selective lysis buffer for a time period sufficiently long to selectively lyse the blood cells in the mammalian blood sample while keeping the micro-organisms intact, thereby forming a lysed sample, wherein the percentage of micro-organism cells that remain intact in the lysed sample is at least two times higher than the percentage of blood cells that remain intact in the lysed sample; and

detecting the presence of the micro-organisms without cultivation of the micro-organisms within said mammalian blood sample.

2. The method according to claim 1 , wherein said time period for the incubating step is between 30 seconds and 10 minutes.

3. The method according to claim 1 , wherein the non-ionic detergent is selected from the group consisting of Nonidet P40, deoxycholate, lgepal CA 630, Triton-X 100, and any combinations thereof.

4. The method according to claim 1 , further comprising centrifuging the incubated final solution and isolating the micro-organisms.

5. The method according to claim 1 , further comprising filtering the incubated final solution on a filter with a pore size that retains micro-organisms on the filter.

6. The method according to claim 1 , further comprising lysing the micro-organisms.

7. The method according to claim 6 , further comprising using a nucleic acid based molecular assay on the lysed micro-organisms.

8. The method according to claim 1 , wherein the method further comprises:

adding an acid or acidic buffer to neutralize the lysed sample.

9. The method according to claim 8 , wherein the lysed sample is neutralized to a pH in a range between 7 and 9.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2019
From: BIOCARTIS N.V.
To: KONINKLIJKE PHILIPS N.V.
Reel/Frame 048550/0422 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2014
From: BIOCARTIS SA
To: BIOCARTIS NV
Reel/Frame 033570/0801 →
CORRECTIVE ASSIGNMENT TO CORRECT THE 4TH INVENTOR'S NAME PREVIOUSLY RECORDED ON REEL 029014 FRAME 0141. ASSIGNOR(S) HEREBY CONFIRMS THE 4TH INVENTOR'S NAME IS ROEL PENTERMAN NOT RON PENTERMAN. Recorded Feb 19, 2013
From: VAN MEERBERGEN, BART EDWARD JOZEF GUSTA; PICIU, OANA MIHAELA; SEFLEK, ZEYNEP; PENTERMAN, ROEL; SCHMIDT, KRISTIANE ANNE; GILL, RON; NEERKEN, SIEGLINDE; PONJEE, MARC WILHELMUS GIJSBERT; VAN DE WIEL, PAUL ARNOLD
To: BIOCARTIS SA
Reel/Frame 029835/0153 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2012
From: VAN MEERBERGEN, BART EDWARD JOZEF GUSTA; PICIU, OANA MIHAELA; SEFLEK, ZEYNEP; PENTERMAN, RON; SCHMIDT, KRISTIANE ANNE; GILL, RON; NEERKEN, SIEGLINDE; PONJEE, MARC WILHELMUS GIJSBERT; VAN DE WIEL, PAUL ARNOLD
To: BIOCARTIS SA
Reel/Frame 029014/0141 →
Priority Claims (1)
EP 09178363 · Dec 7, 2010 · regional
Continuity (1)
Related Publication 20130171615A1 · Jul 4, 2013
Cited By (2)
US 12,253,513 US 12,460,197